Top

General Thoracic and Cardiovascular Surgery

Published in:

01-08-2017 | Original Article

10-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese

Authors: Hideki Teshima, Masahiko Ikebuchi, Yosuke Miyamoto, Ryuta Tai, Toshikazu Sano, Yusuke Kinugasa, Hiroyuki Irie

Published in: General Thoracic and Cardiovascular Surgery | Issue 8/2017

Abstract

Objectives

This study was designed to establish clinical outcomes after aortic valve replacement (AVR) with On-X bileaflet mechanical heart valve.

Methods

Between 2006 and 2014, AVR was performed to 686 patients. Of them, 78 patients using On-X valve were enrolled. The mean age was 65 ± 11 years (ranged 33–85); 65% were men; and 81% were in sinus rhythm preoperatively. Calcific or degenerative tricuspid aortic valve was present in 73%. Concomitant procedures included coronary artery bypass grafting (22%), Bentall (8%), mitral valve procedure (3%) and other (9%). They postoperatively received lower dose warfarin [international normalized ratio (INR), 1.5–2.0] and 100 mg aspirin daily. The follow-up duration averaged 5 years (386.6 patient-years). The follow-up rate was 97.3%.

Results

In-hospital mortality rates were 3.8% (n = 3). Late mortality rates were 2.6% per patient-years (n = 10). Five-year Kaplan–Meier survival rates were 84%. Freedom from major adverse valve-related stroke and cerebral bleeding events was 93.3% (n = 5, 1.29% per patient-years) and 98.6% (n = 1, 0.26% per patient-years, mild subdural hematoma). The incidence of stroke was two patients of transient ischemic attack, two patients of paralytic event, one patient of asymptomatic stroke (self-interruption of anticoagulation). The median INR was 1.92 ± 0.53, ranged from 1.00 to 8.98 (n = 1181) and 51% of all measured INR values were in the therapeutic range of 1.5–2.0.

Conclusions

AVR using On-X valve with low target INR regimen and low-dose aspirin resulted in a significantly low risk of bleeding.

Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease, revised on 10/7/2015. http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_d.pdf. Accessed 30 Jan 2016.

Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A, PROACT Investigators. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014;147(4):1202–10. doi:10.1016/j.jtcvs.2014.01.004 (discussion 1210–1, Epub 2014 Jan 12).CrossRefPubMed

Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006;48:e1–148.CrossRefPubMed

van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, Grunkemeier GL, Bogers AJ, Takkenberg JJ. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881–6.CrossRefPubMed

Teshima H, Ikebuchi M, Sano T, Tai R, Horio N, Irie H. Mid-term results of 17-mm St. Jude Medical Regent prosthetic valves in elder patients with small aortic annuli: comparison with 19-mm bioprosthetic valves. J Artif Organs. 2014;17(3):258–64. doi:10.1007/s10047-014-0770-4 (Epub 2014 May 31).CrossRefPubMed

Okamura H, Yamaguchi A, Nagano H, Itoh S, Morita H, Naito K, Yuri K, Adachi H. Mid-term outcomes after aortic valve replacement with the 17-mm St. Jude Medical Regent valve. Circ J. 2012;76:365–71.CrossRefPubMed

Sawaki S, Usui A, Abe T, Yoshikawa M, Akita T, Ueda Y. Late mortality and morbidity in elderly patients with mechanical heart valves. Asian Cardiovasc Thorac Ann. 2006;14:189–94.CrossRefPubMed

Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–8.CrossRefPubMed

Hanania G. Which heart valve prosthesis for patients aged between 60 and 70 years? Heart. 2003;89:481–2.CrossRefPubMedPubMedCentral

10.

Kahn SS, Trento A, DeRobertis M, Kass RM, Sandhu M, Czer LS, Blanche C, Raissi S, Fontana GP, Cheng W, Chaux A, Matloff JM. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg. 2001;122:257–69.CrossRef

11.

Chan V, Jamieson WR, Germann E, Chang F, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;131:1267–73.CrossRefPubMed

12.

Kulik A, Bedard P, Lam BK, Rubens FD, Hendry PJ, Masters RG, Mesana TG, Ruel M. Mechanical versus bioprosthetic valve replacements in middle-aged patients. Eur J Cardiothorac Surg. 2006;30:485–91.CrossRefPubMed

13.

Rao V, Jamieson WR, Ivanov J, Armstrong S, David TE. Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation. 2000;102:115–9.

14.

Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW, Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–8.CrossRefPubMed

15.

Chambers JB, Pomar JL, Mestres CA, Palatianos GM. Clinical event rates with the On-X bileaflet mechanical heart valve: a multicenterexperience with follow-up to 12 years. J Thorac Cardiovasc Surg. 2013;145(2):420–4. doi:10.1016/j.jtcvs.2011.12.059 (Epub 2012 Feb 17).CrossRefPubMed

16.

Chan V, Jamieson WR, Lam BK, Ruel M, Ling H, Fradet G, Mesana TG. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. J Thorac Cardiovasc Surg. 2010;140(5):1053–8.e2. doi:10.1016/j.jtcvs.2009.10.068 (Epub 2010 May 23).

17.

Tossios P, Reber D, Oustria M, Holland-Letz T, Germing A, Buchwald D, Laczkovics A. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis. 2007;16(5):551–7.PubMed

18.

Ozyurda U, Akar AR, Uymaz O, Oguz M, Ozkan M, Yildirim C, Aslan A, Tasoz R. Early clinical experience with the On-X prosthetic heart valve. Interact Cardiovasc Thorac Surg. 2005;4(6):588–94 (Epub 2005 Sep 16).CrossRefPubMed

19.

Williams MA, van Riet S. The On-X heart valve: mid-term results in a poorly anticoagulated population. J Heart Valve Dis. 2006;15(1):80–6.PubMed

20.

McNicholas KW, Ivey TD, Metras J, Szentpetery S, Marra SW, Masters RG, Dilling EW, Slaughter MS, Mack MJ. North American multicenter experience with the On-X prosthetic heart valve. J Heart Valve Dis. 2006;15(1):73–8 (discussion 79).PubMed

21.

Butchart EG, Payne N, Li HH, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg. 2002;123:715–23.CrossRefPubMed

22.

Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Yoshida K, Tokuda Y, Matsuo T. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circ J. 2002;66:668–70.CrossRefPubMed

23.

Mori T, Asano M, Ohtake H, Bitoh A, Sekiguchi S, Matsuo Y, Aiba M, Yamada M, Kawada T, Takaba T. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients. Ann Thorac Cardiovasc Surg. 2002;8:83–7.PubMed

24.

Borman JB, De Riberolles C. Sorin Bicarbon bileaflet valve: a 10-year experience. Eur J Cardiothorac Surg. 2003;23(1):86–92.CrossRefPubMed

25.

Baykut D, Grize L, Schindler C, Keil AS, Bernet F, Zerkowski HR. Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve. Ann Thorac Surg. 2006;82(3):847–52.CrossRefPubMed

26.

Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, Fukuhara M, Ikeda F, Shikata K, Yoshida D, Yonemoto K, Kamouchi M, Kitazono T, Kiyohara Y. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961–2009). Circulation. 2013;128(11):1198–205. doi:10.1161/CIRCULATIONAHA.113.002424 (Epub 2013 Jul 31).PubMed

27.

Teshima H, Ikebuchi M, Sano T, Kinugasa Y, Nakaoka Y, Tadokoro M, Irie H. Evaluation of the On-X valve in the aortic position by multidetector-row CT. J Heart Valve Dis. 2015 (in press).

Title: 10-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese
Authors: Hideki Teshima
Masahiko Ikebuchi
Yosuke Miyamoto
Ryuta Tai
Toshikazu Sano
Yusuke Kinugasa
Hiroyuki Irie
Publication date: 01-08-2017
Publisher: Springer Japan
Published in: General Thoracic and Cardiovascular Surgery / Issue 8/2017
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI: https://doi.org/10.1007/s11748-017-0778-9

At a glance: The STEP trials

Springer Medicine

10-year results of On-X bileaflet mechanical heart valve in the aortic position: low target INR regimen in Japanese

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2017

Is 18F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?

Extralobar pulmonary sequestration in the middle mediastinum

Long-term durability of preserved aortic root after repair of acute type A aortic dissection

A nationwide survey of aortic valve surgery in Japan: current status of valve preservation in cases with aortic regurgitation

Intravascular ultrasound for transcatheter paravalvular leak closure

Patient-specific simulation: a new avenue to be explored